Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of coadministration of a high-fat meal on
the oral bioavailability of a fixed dose combination of Canagliflozin/extended release
Metformin (CANA/MET XR) tablet, containing 150 mg CANA and 1,000 mg extended release MET in
healthy participants.